Click the play button below for an interview with Paula Lorence at Informex
.

Company Profile

Johnson Matthey Pharma Services (JMPS) provides development and manufacturing services for active pharmaceutical ingredients (APIs). Located ~35 miles west of the Boston/Cambridge area, our recently built facility (2001) offers a design that incorporates both kilo-labs and pilot plant with expansion opportunity. Services provided at JMPS are crucial for development and manufacturing needs of new chemical entities (NCEs) bound for clinical trials and market-approval (commercial use). Strong cGMP and regulatory compliance underscores our services for custom synthesis, process development, scale-up, optimization, validation, and medicinal chemistry. Beyond traditional chemistry services, we can provide solutions for complex molecules by leveraging technologies within our site and the Johnson Matthey group. These technologies include separation technologies (SMB, chiral separations, prep HPLC, diafiltration, etc.), asymmetric/chiral development and analytical technologies, and catalysts (process). Our services are retained for a variety of compounds including small molecules, natural products (extraction), controlled drug substances, and highly potent active ingredients (HPAI). We are able to offer a wide range of manufacturing scale from grams to hundreds of kilograms. To round out these services, our regulatory department has an impeccable track record with FDA compliance audits, and provides CMC, IND, and NDA support to our client's regulatory filings.

Johnson Matthey Pharmaceutical Materials, Inc.-USA (NJ), Johnson Matthey Macfarlan Smith (Scotland) and Johnson Matthey Pharmaceutical Materials-Ireland (Ireland) round out the membership within our pharmaceutical division.

Whether you are a virtual biotech company, large pharmaceutical company or fall somewhere in between, our technical capabilities and services can resolve your API development and manufacturing challenges.